The clinical course of patients receiving allografts is complicated by the induction of a variety of iatrogenic abnormalities. For example, the potent immunosuppressive effects of steroids or cytotoxic drugs such as cyclosporin A and antithymocyte globulin may result in increased susceptibility to infection or neoplasia.' The administration of heterologous antithymocyte globulin may also induce serum sickness like reactions in some patients and in combination with other immunosuppressive drugs may result in reactivation or potentiation of herpes viral infections.23 Recent investigations in cardiac allograft recipients have shown that many patients develop immunological disturbances including de novo generation of circulating immune complexes and pronounced C4 hypocomplementaemia.4 Bacterial and herpes viral antigens as well as antithymocyte globulin have been implicated as constituents of these circulating immune complexes.56 In addition, many patients transiently produce a range of antiheart antibodies.7 None of these variables, however, has been shown to correlate with acute cardiac rejection.
In the present study concentrations of the acute phase reactant C reactive protein (CRP) in heart transplant recipients were examined. This work was performed to determine whether measurement of CRP values would aid the identification of intercur- Although the results in Table 4 indicate a lack of correlation between CRP values and cardiac rejection, the association of increased CRP concentration with infection may have obscured a relation with rejection. The data were thus edited as far as possible to exclude CRP rises associated with recognised infection, and then analysed in relation to the cardiac biopsy results. Thirteen samples with raised CRP concentrations unassociated with infection gave a median value of 4-4 mg/100 ml (range 2l2-12-0). Six of 13 biopsies taken at the same time were positive for rejection (46%), with a median value of 5.4 mg/100 ml (range 3.1-12.0). The biopsy negative group had a median value of 4-3 mg/100 ml (range 2.2-6-6). The CRP values were conversely examined in all samples with a corresponding biopsy showing rejection. The results showed that 8/37 (22%) samples had raised CRP concentrations, with a median value of 0 7 mg/100 ml (range <0 6-11.8) . These results indicate that even when clinical infections are eliminated from the data, raised CRP values do not correlate with rejection. Similarly, when only positive biopsies are considered, median CRP values are low.
Discussion
Much information has emerged recently on the role of CRP in disease.9 For example, CRP opsonises pathogenic bacteria, interacts with various products of inflammation, and fixes human complement.'°" CRP concentrations are normally low'2 but rise predictably two to three days after various forms of operation'0'3'4 and fall rapidly over the next two days. This pattern was also found in the heart transplant recipients studied here.
CRP concentrations also rise dramatically in patients with bacterial infections,9 10 but only modestly, if at all, in most viral infections.'5-'7 One recent report, however, has shown that CRP values rise substantially in patients with measles, though only when the rash appears or if the disease is complicated by pneumonia.'8 CRP titres have also been found to be raised during rubella viral exanthem.'9 In heart transplant recipients the rises in CRP values were mostly associated with the presence of infection in patients receiving antithymocyte globulin only ( Table 2) . Patients receiving cyclosporin A only had no rises in CRP, however, while those receiving both antithymocyte globulin and cyclosporin A gave a negative association with clinical infection. The explanation of this result is not clear. It is possible that infection was present sub-clinically in these patients. Certainly, cyclosporin A in low doses induces fewer infections, with a lower incidence and severity of acute rejection compared with antilymphocyte serum or antithymocyte globulin,20 and this seems to be the case in the patients in this study. This suggests that the rises in CRP concentration in group 3 were due either to infection rendered subclinical by cyclosporin A treatment or to some other cause of inflammation.
Analysis of the type of clinical infection found in heart transplant recipients showed that the incidence and degree of raised CRP values were much -higher during episodes of bacterial infection than viral infection (Table 3) . It is not certain, however, whether the three instances of increased CRP values associated with herpes virus infection were the consequence of such infection or a coincidence. Certainly, analysis of circulating immune complex components in these patients suggests the presence of subclinical bacterial infection.6 Increases in CRP seen in the patient with aspergillus infection are consistent with the known ability of CRP to bind aspergillus extracts.'0 It is also of interest to note that CRP values were consistently high in the patient with fatal toxoplasmosis.
In addition to intercurrent infections, heart transplant recipients undergo episodes of acute rejection of varying severity. 
